Dynavax Technologies stock trades near its 52-week high
Published on 09/25/2026 at 13:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dynavax Technologies stock (ISIN US2681581009) stood at USD 15.50 on Nasdaq on February 11, 2026, just 1.46 percent below its 52-week high of USD 15.73. The same quote showed a 52-week low of USD 9.20, giving the stock a clearly defined valuation range for investors. DailyMed updated the HEPLISAV-B label on September 18, 2026.
The stock sits near its yearly peak
Dynavax carried a market capitalization of USD 1,820,087,035 on February 11, 2026. At USD 15.50, the stock was 68.5 percent above the 52-week low of USD 9.20, while the gap to the high was 1.46 percent.
Trading volume reached 5,659,539 shares on that date, compared with average volume of 3,161,713 shares. The difference equals 2,497,826 shares, or 79.0 percent above the average, making turnover a central part of the market snapshot.
HEPLISAV-B anchors the business
Dynavax develops and commercializes vaccines, with HEPLISAV-B as its lead commercial product and CpG 1018 as its proprietary adjuvant platform. According to DailyMed on September 18, 2026, HEPLISAV-B is indicated to prevent infection caused by all known hepatitis B subtypes and is approved for adults 18 years and older.
The product label also identifies 20 micrograms of hepatitis B surface antigen and 3,000 micrograms of CpG 1018 adjuvant in each 0.5-milliliter dose. That formulation links Dynavax's commercial vaccine to the company's broader adjuvant technology.
Valuation stays close to the upper boundary
The February 11, 2026 market snapshot places USD 15.50 close to the upper end of the 52-week range from USD 9.20 to USD 15.73. The combination of USD 1,820,087,035 in market value and volume 79.0 percent above average gives investors two concrete measures of the stock's trading profile.
Dynavax stock trades at USD 15.50
Dynavax Technologies stock stood at USD 15.50 on Nasdaq on February 11, 2026. Its 1.46 percent distance from the 52-week high of USD 15.73 is the key reference for the quoted level.
Dynavax Technologies stock at a glance
- Company: Dynavax Technologies Corporation
- ISIN: US2681581009
- Ticker: DVAX
- Trading venue: NASDAQ
- Price (as of February 11, 2026): USD 15.50
- Market capitalization: USD 1,820,087,035 (as of February 11, 2026)
- 52-week range: USD 9.20-15.73 (as of February 11, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
